IN PARTNERSHIP
prevent them from driving, using stairs, or walking long distances. Researchers can make reasonable
accommodations by including multiple trial locations, offering more choices for clinic appointment times, providing transportation, including childcare options, and offering translation services.
4. Enlist patient navigators Patient navigators play an important role in supporting participants before, during, and after clinical trials. From answering simple questions to helping participants overcome personal obstacles, navigators can improve clinical trial participation and completion rates. Navigators can also assist with scheduling appointments, making transportation arrangements, and ensuring reasonable accommodations for patients with disabilities.
5. Enhance marketing strategies Marketing strategies play a vital role in attracting diverse participants. For example, radio or TV ads may reach audiences with limited internet access, and community events allow researchers to connect with individuals who would not otherwise be aware of the study. Marketing campaigns should focus on
geographic locations and media outlets targeting populations the research intends to serve.
6. Establish trust Building trust can help increase clinical trial participation rates. This is especially true for minority populations who may be distrustful due to past research practices; the Tuskegee syphilis study being among them (a 40-year experiment run without the participants’ consent). Researchers must answer participant questions, clearly explain the trial’s design, and inform participants of their roles and responsibilities to build trust and rapport. Ensuring that participants feel safe, informed, and supported throughout the clinical trial is essential for the enrolment and retention of diverse populations.
7. Partner with local organisations Researchers must look into finding creative ways to attract diverse populations during the enrolment process.
76 | Outsourcing in Clinical Trials Handbook One strategy is to partner with local
organisations, such as churches, civic groups, and non-profit organisations to increase awareness of clinical studies. Since many community-based organisations
already have established, trusted relationships with members of their community, researchers may be able to host information sessions or provide community education programmes in these settings. Community gatherings can help researchers
connect with potential participants and begin establishing rapport. It’s worth remembering that local organisations may also have bilingual staff or community members available to help translate during information sessions.
8. Leverage technology Participants who cannot travel to a specific geographical location for an information session, consultation, or screening may be able to leverage technology to attend virtually. Researchers can leverage technology to: • distribute e-consent forms • schedule appointments • conduct telemedicine sessions • collect patient-reported outcome measures (PROMs)
• access translation resources Technology can significantly reduce participation barriers for minority populations.
9. Hire multilingual staff Researchers may also consider hiring multilingual staff to ensure that all participants have equal access to information related to clinical trials. When research participants fully understand the study’s design and expectations, they are more likely to stay engaged and complete the trial. Multilingual staff can assist research participants with solving problems and overcoming barriers to participation. However, if study budget constraints limit your
ability to hire multilingual staff, make use of an outsourced professional translation and interpreting language service provider with experience in life sciences and clinical trials.
The future of diversity in clinical trials To improve diversity in clinical trials, researchers must enlist various strategies to enrol and retain minority populations.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
